Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Zylox-Tonbridge Medical Technology Co., Ltd. Class H ( (HK:2190) ) has issued an update.
Zylox-Tonbridge Medical Technology Co., Ltd. has announced an upcoming board meeting scheduled for August 19, 2025. The meeting will focus on approving and publishing the interim results for the first half of the year, which could have implications for the company’s financial performance and market positioning.
The most recent analyst rating on (HK:2190) stock is a Buy with a HK$18.60 price target. To see the full list of analyst forecasts on Zylox-Tonbridge Medical Technology Co., Ltd. Class H stock, see the HK:2190 Stock Forecast page.
More about Zylox-Tonbridge Medical Technology Co., Ltd. Class H
Zylox-Tonbridge Medical Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. It operates within the medical technology industry, focusing on the development and provision of medical devices and technologies.
Average Trading Volume: 616,819
Technical Sentiment Signal: Buy
Current Market Cap: HK$7.15B
Find detailed analytics on 2190 stock on TipRanks’ Stock Analysis page.